Endo Int'l (ENDP) Closes Par Pharma Acquisition; Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
RBC Capital Cuts Price Target on Endo Int'l (ENDP) Following Guidance Update
September 29, 2015 7:42 AM EDTRBC Capital maintained a Top Pick rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $100.00 (from $107.00), following a guidance update. ENDP pointed to a 3Q range of $720-740 million in revenue which is 4% below consensus at the midpoint.
Analyst... More
Guggenheim Reiterates Buy on Endo Int'l (ENDP) Following Updated Guidance
September 28, 2015 11:24 AM EDTGuggenheim reiterated a Buy rating and $110.00 price target on Endo International plc (NASDAQ: ENDP) following the company's updated financial guidance. Analyst Louise Chen continues to believe ENDP has set the stage for better-than-expected growth in '16+ driven by Xiaflex, Belbuca and the generics... More
